Acrospire Investment Management LLC - TITAN PHARMACEUTICALS INC DE ownership

TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314309. A total of 57 filers reported holding TITAN PHARMACEUTICALS INC DE in Q2 2016. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.

Quarter-by-quarter ownership
Acrospire Investment Management LLC ownership history of TITAN PHARMACEUTICALS INC DE
ValueSharesWeighting
Q2 2017$3,000
-96.0%
1,634
-92.8%
0.00%
-95.2%
Q1 2017$75,000
-60.7%
22,670
-52.6%
0.06%
-21.5%
Q4 2016$191,000
+5.5%
47,779
+54.9%
0.08%
-34.2%
Q3 2016$181,000
+2485.7%
30,847
+2328.9%
0.12%
+2300.0%
Q2 2016$7,0001,2700.01%
Other shareholders
TITAN PHARMACEUTICALS INC DE shareholders Q2 2016
NameSharesValueWeighting ↓
PERKINS CAPITAL MANAGEMENT INC 545,000$122,0000.10%
Virtu Financial LLC 236,182$53,0000.00%
Planning Solutions Group LLC 14,293$3,0000.00%
Cutter & CO Brokerage, Inc. 10,000$2,0000.00%
Blume Capital Management, Inc. 2,546$1,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 17,483$4,0000.00%
Wealthspire Advisors, L.P. 8,235$2,0000.00%
Advisor Group, Inc. 2,100$00.00%
FLAGSHIP HARBOR ADVISORS, LLC 2,250$00.00%
View complete list of TITAN PHARMACEUTICALS INC DE shareholders